Shanghai Fosun Pharmaceutical (Group) Co (08HH) AI Stock Analysis
Shanghai Fosun Pharmaceutical (Group) Co
(Frankfurt:08HH)
No summary available
Shanghai Fosun Pharmaceutical (Group) Co (08HH) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 5.76B
- Dividend Yield
- 2.60%
- Average Volume (3M)
- 3,496
- Price to Earnings (P/E)
- 17.0
- Beta (1Y)
- 0.28
- Revenue Growth
- 2.13%
- EPS Growth
- 1.61%
- Country
- Germany
- Employees
- 40,603
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Drug Manufacturers - Specialty & Generic
Shanghai Fosun Pharmaceutical (Group) Co Business Overview & Revenue Model
Company Description
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a comprehensive healthcare enterprise, operating across Mainland China and international markets. Its principal activities include the research, development, production, and commercialization of phar...
Shanghai Fosun Pharmaceutical (Group) Co Peers Comparison
Overall Rating
HK:151377Outperform
HK:369274.5Outperform
HK:332068Neutral
HK:086761Neutral
HK:087457Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:1513 | 77Outperform | HKD 26.72B | 16.30 | 11.32% | 6.71% | -9.56% | -23.22% |
| HK:3692 | 75Outperform | HKD 196.24B | 24.91 | 18.26% | 1.50% | 24.97% | 43.23% |
| HK:3320 | 68Neutral | HKD 29.12B | 6.18 | 7.92% | 5.17% | 7.94% | 52.83% |
| HK:0867 | 61Neutral | HKD 23.94B | 13.40 | 8.60% | 3.50% | 14.80% | -2.88% |
| HK:0874 | 57Neutral | HKD 35.32B | 14.74 | 5.57% | 6.71% | 6.00% | -23.05% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:08HH | Shanghai Fosun Pharmaceutical (Group) Co Class H | 1.86 | -0.67 | -26.34% | |
| HK:0867 | China Medical System Holdings | 9.81 | -3.65 | -27.10% | |
| HK:0874 | Guangzhou Baiyunshan Pharmaceutical Holdings Company Class H | 12.86 | -5.10 | -28.41% | |
| HK:1513 | Livzon Pharmaceutical Group Class H | 23.18 | -5.02 | -17.81% | |
| HK:3320 | China Resources Pharmaceutical Group Ltd. | 4.63 | -0.11 | -2.26% | |
| HK:3692 | Hansoh Pharmaceutical Group Company Limited | 32.36 | -2.99 | -8.45% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.